• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHS2400022 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) New Drug Application 2024-03-27 view
CYHB2400431 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) Supplementary Application 2024-03-27 view
CXHS2400021 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) New Drug Application 2024-03-27 view
CYHB2400430 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) Supplementary Application 2024-03-27 view
JXHB2300086 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) Supplementary Application 2023-05-25 AstraZeneca AB view
JXHB2300085 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) Supplementary Application 2023-05-25 AstraZeneca AB view
JXHL2200063 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) Import Drug Application 2022-03-22 view
JXHL2200064 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) Import Drug Application 2022-03-22 view
JXHL2200062 赛沃替尼片 savolitinib Tablet Chemical Drugs(2.4) Import Drug Application 2022-03-22 view
CYHB2102296 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) Supplementary Application 2021-12-14 view
CYHB2102295 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) Supplementary Application 2021-12-14 view
CXHL2101032 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) New Drug Application 2021-04-15 Hutchison MediPharma Co Ltd view
CXHL2101033 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) New Drug Application 2021-04-15 Hutchison MediPharma Co Ltd view
CXHL2100211 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) New Drug Application 2021-03-31 和记黄埔医药(上海)有限公司 Hutchison MediPharma Co Ltd In Review 2021-03-30 view
CXHL2100210 赛沃替尼片 savolitinib Tablet Chemical Drugs(1) New Drug Application 2021-03-31 和记黄埔医药(上海)有限公司 Hutchison MediPharma Co Ltd In Review 2021-03-30 view